Latest News

In a CRISPR first, therapy intended to cure HIV patient appears safe — though ineffective

An HIV-positive man in China is doing well after receiving infusions of donor cells whose genes were edited with CRISPR 19 months ago, scientists reported on Wednesday in the New England Journal of Medicine. That makes him the longest-followed individual ever to be treated with CRISPR, a genetic technology that has inspired sky-high hopes for disease cures and spawned a multibillion-industry in just four years.

The patient’s mere survival, apparently without side effects from a treatment that a few studies suggested might trigger cancer or other disastrous genetic damage, provides some assurance that CRISPR-based therapies might be safe — and overshadows the fact that the intervention fell well short of its goal: eliminating HIV from the man’s cells.

Read the rest…

Source link

Related posts

Medical News Today: Diabetes: Best diets for weight loss

Newsemia

Coronavirus Patient Asks Amazon’s 'Alexa' For Help Before Death

Newsemia

STAT Plus: Progressives warn Democratic leaders that piecemeal drug pricing reforms could fracture the party

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World